Clinical Trial Update: Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial comparing continuing olanzapine to switching to quetiapine in overweight or obese adults with schizophrenia or schizoaffective disorder; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Quetiapine (quetiapine)
• olanzapine (olanzapine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED